(3-ENDO)-3-(3-METHYL-5-(1-METHYLETHYL)-4H-1,2,4-TRIAZOL-4-YL)-8-(PHENYLMETHYL)-8-AZABICYCLO(3.2.1)OCTANE
UNII C6GB2T8G7Z
Substance Identification & Data
This profile provides standardized clinical and technical data for (3-endo)-3-(3-methyl-5-(1-methylethyl)-4h-1,2,4-triazol-4-yl)-8-(phenylmethyl)-8-azabicyclo(3.2.1)octane, uniquely identified by the FDA Unique Ingredient Identifier (UNII) C6GB2T8G7Z.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 858651-22-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H28N4 YHGHRIAZABSSGB-BWTSREIZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (3-endo)-3-(3-methyl-5-(1-methylethyl)-4h-1,2,4-triazol-4-yl)-8-(phenylmethyl)-8-azabicyclo(3.2.1)octane. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.